1.
Am J Health Syst Pharm
; 58(7): 598-602, 2001 Apr 01.
Article
in English
| MEDLINE
| ID: mdl-11296610
Subject(s)
Antiemetics/therapeutic use , Antineoplastic Agents/adverse effects , Ondansetron/therapeutic use , Vomiting/chemically induced , Vomiting/prevention & control , Administration, Oral , Antiemetics/administration & dosage , Antiemetics/economics , Child , Clinical Protocols , Cost Control , Costs and Cost Analysis , Humans , Injections, Intravenous , Ondansetron/administration & dosage , Ondansetron/economics , Vomiting/economics
2.
Ann Pharmacother
; 28(2): 282, 1994 Feb.
Article
in English
| MEDLINE
| ID: mdl-8173153